Study on communication about dementia risk for MCI and SCD
Part of Brain & nervous system, Mental health clinical trials.
This study looks at how doctors talk to patients and their care partners about test results that show risk of dementia. It is for people who have very early memory concerns (SCD) or mild cognitive impairment (MCI) and have had a spinal tap to check for Alzheimer's markers.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been told you have mild cognitive impairment (MCI) or subjective cognitive decline (SCD) — very early memory changes
- You had a lumbar puncture (spinal tap) as part of your check-up
- You are 80 years old or younger
- Your score on a memory test (MMSE) was 24 or higher
- You do not have a serious mental illness like schizophrenia or bipolar disorder, and you do not currently struggle with heavy alcohol or drug use
- A family member or friend came with you to the visit where test results were discussed
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study at Duke University is looking for people aged 25 to 80 who may be at risk for Alzheimer's disease. It involves brain scans (MRI and PET) and a spinal tap to learn more about the disease and find better ways to detect and treat it early.
This study looks at spinal fluid and MRI results in people with Alzheimer’s disease, frontotemporal dementia, or normal thinking (controls). It aims to understand differences in brain-related cells and measure what might help explain or track these conditions.
This study screens people aged 60–80 for early signs of Alzheimer's disease in a community setting. Researchers will ask you questions and may perform brain imaging to understand who might benefit from early detection and treatment.
This study follows people over time to better understand how memory and thinking complaints progress in early Alzheimer’s disease (from “subjective cognitive decline” to mild cognitive problems). It may help researchers understand who is likely to decline and how symptoms change, which could support future treatments.
This study tests a new questionnaire designed to help doctors better understand early memory or thinking problems. It takes place at a memory clinic in Munich and is for people who are already coming in for dementia testing.
This research study looks at people who have noticed problems with memory or thinking (like trouble focusing or finding words) and visit their primary care doctor for help. It aims to better understand and diagnose conditions that cause these symptoms, such as Alzheimer's disease.
Hear when a new Subjective Cognitive Decline (SCD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.